$649M
$74.7 Million
0.01% of portfolio
24,162,383
Q2 2025
Added 1.56%
$0
$143 Million
0.01% of portfolio
2,603,174
Q2 2025
Added 5.54%
$0
$102 Million
0.01% of portfolio
3,118,575
Q2 2025
Added 3.71%
$0
$143 Million
0.01% of portfolio
4,441,003
Q2 2025
Added 7.07%
$0
$154 Million
0.01% of portfolio
2,447,393
Q2 2025
Added 4.33%
$0
$203 Million
0.01% of portfolio
4,052,467
Q2 2025
Added 2.93%
$0
$101 Million
0.01% of portfolio
4,269,511
Q2 2025
Added 2.14%
$0
$203 Million
0.01% of portfolio
12,147,764
Q2 2025
Added 8.51%
$0
$179 Million
0.01% of portfolio
7,197,054
Q2 2025
Reduced 0.71%
$0
$201 Million
0.01% of portfolio
5,301,983
Q2 2025
Added 6.18%
$0
$192 Million
0.01% of portfolio
2,356,024
Q2 2025
Added 4.88%
$0
$117 Million
0.01% of portfolio
6,156,993
Q2 2025
Added 0.77%
$0
$198 Million
0.01% of portfolio
2,403,953
Q2 2025
Added 6.43%
$0
$162 Million
0.01% of portfolio
3,161,171
Q2 2025
Added 18.45%
$0
$163 Million
0.01% of portfolio
5,646,653
Q2 2025
Added 14.41%
$0
$106 Million
0.01% of portfolio
3,248,611
Q2 2025
Added 20.34%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 61.52%
$291M
$16 Million
0.0% of portfolio
4,811,733
Q2 2025
Added 37.79%
$0
$53 Million
0.0% of portfolio
1,968,289
Q2 2025
Added 2.99%
$8.43B
$70.8 Million
0.0% of portfolio
350,151
Q2 2025
Reduced 10.38%
$3.78B
$71.9 Million
0.0% of portfolio
531,444
Q2 2025
Added 13.69%
$0
$2.42 Million
0.0% of portfolio
48,569
Q2 2025
Reduced 4.34%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 13.38%
Titan Pharmaceuticals Inc De
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 50.0%
$109M
$2.82 Million
0.0% of portfolio
525,552
Q2 2025
Added 162.74%
$4.68B
$51.4 Million
0.0% of portfolio
3,064,455
Q2 2025
Reduced 11.53%
$343M
$883,000
0.0% of portfolio
144,913
Q2 2025
Reduced 25.32%
$0
$0
0.0% of portfolio
32
Q2 2025
Added 60.0%
$0
$0
0.0% of portfolio
2
Q2 2025
Added 100.0%
Rivernorth Cap And Incm Fd I
-
$0
0.0% of portfolio
-
Q2 2025
New
$419M
$6.46 Million
0.0% of portfolio
251,521
Q2 2025
Added 12.36%
$75M
$84,000
0.0% of portfolio
38,810
Q1 2025
Reduced 5.68%
Corbus Pharmaceuticals Hldgs
-
$0
0.0% of portfolio
-
Q2 2025
Added 107.54%
-
$0
0.0% of portfolio
-
Q2 2025
Added 44.9%
$2.45B
$17.6 Million
0.0% of portfolio
483,489
Q2 2025
Added 9.58%
$168M
$660,000
0.0% of portfolio
67,717
Q2 2025
Added 12.87%
$5.65B
$33.1 Million
0.0% of portfolio
524,480
Q2 2025
Added 4.05%
$236M
$3.21 Million
0.0% of portfolio
1,249,278
Q2 2025
Reduced 14.31%
$7.86B
$43.1 Million
0.0% of portfolio
6,268,569
Q2 2025
Added 3.68%
$1.08B
$8.58 Million
0.0% of portfolio
706,544
Q2 2025
Added 171.24%
$3.89B
$6.67 Million
0.0% of portfolio
1,828,288
Q2 2025
Added 207.89%
$452M
$8.39 Million
0.0% of portfolio
1,421,944
Q2 2025
Reduced 12.09%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 21.67%
Mawson Infrastructure Group
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 1.72%
$0
$15,000
0.0% of portfolio
533
Q2 2025
Reduced 98.2%
-
$0
0.0% of portfolio
-
Q4 2024
New
$0
$10.6 Million
0.0% of portfolio
107,565
Q2 2025
Added 6.71%
$600M
$1.1 Million
0.0% of portfolio
259,023
Q2 2025
Reduced 17.06%
$0
$13.1 Million
0.0% of portfolio
298,113
Q2 2025
Added 21.42%
Mountain Lake Acquisition CO
-
$0
0.0% of portfolio
-
Q2 2025
Added 45.45%